Likewise, the investigation of the potential regulation of drug-induced cytotoxicity by GSK-3 - expected to occur in light of its role in the NF-κB signaling - would provide hints to determine the feasibility of this potentially useful therapeutic approach in MM therapy. Here, NFKB1 is linked to Miyoshi myopathy.